Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-001553

ChemoCentryx, Inc. · CCXI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Thomas J. Schall
Officer — President and CEO · Director
Period of report
Jan 1, 2018
Accepted (ET)
Jan 3, 2018 · 7:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001340652

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockJan 1, 2018M33,333$0.00A2,188,378D
Common StockJan 1, 2018M33,333$0.00A2,221,711D
Common StockF3Jan 1, 2018F36,717$5.95D2,184,994D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Stock UnitsF4,F5—Jan 1, 2018M33,333D——Common Stock33,33333,334D
Restricted Stock UnitsF4,F6—Jan 1, 2018M33,333D——Common Stock33,33366,667D

Explanation of responses